An alternative explanation for the modest results of EGFR molecular targeting in this type of tumour is the fact that PDAC is a complex, heterogeneous neoplasm that relies on multiple signalling pathways to promote tumour cell proliferation and invasion. The gene discussed is EGFR; the disease is neoplasm.